AHRP Speaks Out Dec 12, 2005: Mental Health Screening: A PhRMA Friendly Remedy for Societal Problems. Presentation by Vera Sharav, American Public Health Association Nov 2005: Analysis of S. 1873 – The Biodefense and Pandemic Vaccine and Drug Development Act of 2005 – Karen R. Effrem, MD June 1-3, 2005:…
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and The New York Times focus on the Vioxx fall out–a case that encapsulates the corrupt practices in drug research. Merck and FDA officials intervened to conceal the lethal cardiac effect of Vioxx. Mother…
UK Pharma Association Displaying Acute Anxiety / FDA approves Focalin XR for ADHD Tue, 14 Jun 2005 The good news is that British physicians are taking a more cautious approach and cutting down on their prescribing of drugs whose adverse side effects often do more harm than good. But the…
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What…
Depressing news for GSK Thu, 14 Apr 2005 A class lawsuit by US investors has been filed against GlaxoSmithKline in the US federal District Court in New York, alleging violation of securities laws. The suit charges GSK issued “false or misleading public statements” about the antidepressant, Paxil (Seroxat). The law…
Zyprexa – Risperdal – Abilify – Clozari Kill Elderly Tue, 12 Apr 2005 The long-denied, hidden truth about the deadly risks of antipsychotic drugs is about to be disclosed to the public. The New York Times reports that the FDA will now require Black Box warnings about the increased risk…
NY Times Public Advocate: Extra! Extra! Read Not Quite Everything About It! Sun, 10 Apr 2005 The New York Times Public Editor pointed the finger at the Times for its unprofessional journalistic lapses–such as prematurely publishing scoops planted by one of the parties to a dispute. The issue involved complaints…
Acting EPA Chief Withdraws Controversial Pesticide Experiment – LAT / NYT Sat, 09 Apr 2005 “We are gratified that when this abominable experiment was exposed to the public, the pesticide industry and its EPA advocates had to surrender." Senator Barbara Boxer has expressed her concern “over the larger philosophy behind…
UK Parliament Report Re: Pharma Influence / US RegulatorsComatose as 258 Fatal Suicides Linked to Neurontin Wed, 6 Apr 2005 The Health Committee of the British House of Commons, has just released its report, “The Influence of the Pharmaceutical Industry.” This landmark document is not just of value to UK…
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting Openness, Full Disclosure, and Accountability www.ahrp.org Statement by Vera Hassner Sharav Founder & President, AHRP April 1, 2005 Anthrax Band Reunion Press Conference New York City My name is Vera Hassner Sharav, and I am president of The Alliance for Human Research Protection:…
EPA Nominee Challenged in Senate Over Children’s Pesticide Experiment Thu, 07 Apr 2005 AHRP applauds Senator Barbara Boxer for pledging to hold up the confirmation of Stephen Johnson, the President’s nominee to head the Environmental Protection Agency, until he pulls the plug on “the appalling, unethical, and immoral” children’s pesticide…
